Overview
This short course will review the current state of the art in REMS and aRMMs, review, and highlight the convergence of the most recent and relevant guidance updates from FDA, EMA and CIOMS. It will also examine opportunities for risk management activities, and the customer engagement that they require, to bring added organizational and asset value beyond compliance. The course will explore how these opportunities can drive new ways of collaborative, cross-functional working, and more fully integrate these critical risk management activities with ongoing RWE collection.
Registered attendees for this Short Course will receive access to the course onsite and presentation materials.
Have an account?